Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Muscle Energy Technique on Forward Head Posture and Cervical Mobility in Visually Impaired Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04716348
Recruitment Status : Recruiting
First Posted : January 20, 2021
Last Update Posted : May 11, 2021
Sponsor:
Information provided by (Responsible Party):
Noha Elserty, Egyptian Chinese University

Brief Summary:
Forward head posture is one of the most common postural deviation seen among visually impaired children and, it is characterized by hyperextension of upper cervical and flexion of lower cervical spine. These changes lead to muscle imbalance and resulting in weakness of the deep cervical flexors, shortening of the opposing cervical extensors and reduction in cervical range of motion. Muscle energy technique is a manual therapy technique using in the treatment of shortened muscles, muscle weakness, restricted joints range of motion. so this study aimed to investigate the efficacy of muscle energy technique on forward head posture and cervical mobility in visually impaired children.

Condition or disease Intervention/treatment Phase
Children With Visual Disabilities Procedure: muscle energy technique Not Applicable

Detailed Description:
subjects will be allocated according to the inclusion and exclusion criteria from different schools for visually impaired children. They will be divided randomly into study group and control group. Study group will be participated in suboccipital muscle energy technique. Control group will be participated in sham technique. The duration of treatment for both groups will be 3 times/week for 6 weeks. Autodesk AutoCAD software will be used to analyze the measured angles and CROM will be used to assess cervical mobility

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Efficacy of Muscle Energy Technique on Forward Head Posture and Cervical Mobility in Visually Impaired Children
Actual Study Start Date : February 1, 2021
Estimated Primary Completion Date : June 1, 2021
Estimated Study Completion Date : June 1, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: group A
suboccipital muscle energy technique
Procedure: muscle energy technique
muscle energy technique for suboccipital muscles

Sham Comparator: group B
sham muscle energy technique
Procedure: muscle energy technique
muscle energy technique for suboccipital muscles




Primary Outcome Measures :
  1. change in craniovertebral angle [ Time Frame: baseline pre intervention and immediately after the intervention ]
    analysis of craniovertebral angle form lateral view performed by AUTOCAD program

  2. change of cervical range of motion [ Time Frame: baseline pre intervention and immediately after the intervention ]
    measurement of cervical range of motion including cervical flexion, cervical extension, cervical side bending, and cervical rotation. these measurement will be applied by CROM device



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   8 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Visual acuity will be 6/24, 6/36 and 6/60 after correction.
  • Wearing glasses more than one year.
  • Craniovertebral angle < 50°.
  • Functional hearing.

Exclusion Criteria:

  • Injury of cervical region (e.g: atlantoaxial instability).
  • Cervical spine deformities or/disorders.
  • History of previous cervical spine surgery.
  • Rheumatic and congenital heart disease.
  • Regular participation in any sport activities.
  • Intellectual or/mental disabilities

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04716348


Contacts
Layout table for location contacts
Contact: Noha S Elserty, PhD +201006709648 noha_elserty@hotmail.com
Contact: Eman W Mahmoud, PhD +201008079576 Eman.wagdy@pt.bsu.edu.eg

Locations
Layout table for location information
Egypt
Noha Elserty Recruiting
Cairo, Egypt
Contact: Noha S Elserty         
Sponsors and Collaborators
Egyptian Chinese University
Investigators
Layout table for investigator information
Principal Investigator: Noha S Elserty, PhD Lecturer of physical therapy- Egyptian Chinese University
Layout table for additonal information
Responsible Party: Noha Elserty, lecturer of physical therapy, Egyptian Chinese University
ClinicalTrials.gov Identifier: NCT04716348    
Other Study ID Numbers: Egyptian Chinese University
First Posted: January 20, 2021    Key Record Dates
Last Update Posted: May 11, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: supporting information that will be shared after publication of the study
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Time Frame: after publishing the study

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No